Valuation: Ginkgo Bioworks Holdings, Inc. ; P/E ratio * · EV / Sales * · Yield *. Ginkgo Bioworks Holdings Inc ; Previous Close: ; Volume: ; 3 Month Average Trading Volume: ; Shares Out (Mil): ; Market Cap: Ginkgo Bioworks platform is enabling biotechnology applications across diverse markets, from food and agriculture to industrial chemicals to pharmaceuticals. Ginkgo Bioworks Holdings, Inc. operates as a holding company. The Company, through its subsidiaries, develops platform to program cells from food to materials. More programs = more overhead costs, more labor costs, more R&D costs. Doing business in biotech is expensive. Ginkgo had a revenue decrease of.
Ginkgo Bioworks Holdings, Inc. Class A Common Stock (DNA) Pre-Market. Data is currently not available. Data last updated Sep 3, AM ET. This page. Octarine Bio and Ginkgo Bioworks Announce Partnership to Produce Natural Colors Ginkgo Bioworks Announces Proposed Public Offering of Class A Common Stock. Ginkgo Bioworks DNA:NYSE · Open · Day High · Day Low · Prev Close · 52 Week High · 52 Week High Date09/06/23 · 52 Week Low · 52 Week. To buy fractional shares of Ginkgo Bioworks, Inc stock, you'll need to sign up for Stash and open a personal portfolio. Stash allows you to purchase smaller. Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations. Ginkgo Bioworks Holdings, Inc. (DNA) ; Jul 10, , , , , ; Jul 9, , , , , Ginkgo Bioworks Holdings Inc. ; Open. $ Previous Close$ ; YTD Change. %. 12 Month Change. % ; Day Range - 52 Wk Range - Company Ginkgo Bioworks Holdings, Inc. Equities. DNA. USX Biotechnology & Medical Research. Market Closed - Nyse. Other stock markets. The share price of Ginkgo Bioworks Holdings, Inc. as of August 22, is $ / share. This is an increase of 3,% from the prior week. The Factor. Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) institutional ownership structure shows current positions in the company by institutions and funds, as well as latest. Ginkgo Bioworks Holdings NYSE:DNA Stock Report ; Last Price. US$ ; Market Cap. US$m ; 7D. % ; 1Y. % ; Updated. 01 Sep,
Ginkgo Bioworks Holdings Inc (DNA) stock price, GURU trades, performance, financial stability, valuations, and filing info from GuruFocus. Ginkgo Bioworks Holdings, Inc. is a biotech company. Its platform is market agnostic and enables biotechnology applications across diverse markets. End-to-End Capabilities. Unparalleled Scale. Explore Ginkgo's capabilities for therapeutics and vaccines, agriculture, nutrition and wellness, and more. Ginkgo Bioworks Holdings, Inc. is a biotech company. Its platform is market agnostic and enables biotechnology applications across diverse markets. Ginkgo Bioworks stock has % downside, according to 1 Wall Street analyst. May 20, Motley Fool Is Ginkgo Bioworks Holdings Stock a Buy? The current price of DNA is USD — it has decreased by −% in the past 24 hours. Watch Ginkgo Bioworks Holdings, Inc. stock price performance more. Stock Info · SEC Filings · Quarterly Reports · Annual Reports · Sustainability · Governance · Executive Management · Board of Directors · Committee Composition. Corporate Profile. Headquartered in Boston, Ginkgo Bioworks is building a platform to enable customers to program cells as easily as we can program computers. Ginkgo Bioworks Holdings (NYSE:DNA) is a biotechnology company that offers a platform for cell programming that enables the biological production of various.
Ginkgo Bioworks Holdings Inc. ; Next Fiscal Year Estimate, ; Median PE on Next FY Estimate, N/A ; High, $ ; Median, $ ; Low, $ Exchange. NYSE ; Sector. Health Care ; Industry. Biotechnology: Biological Products (No Diagnostic Substances) ; 1 Year Target. $ ; Today's High/Low. $/$. Ginkgo Bioworks went public on the New York Stock Exchange via a SPAC merger on September 17, Ginkgo Bioworks Holdings, Inc. Company type, Public. Ginkgo Bioworks announce plans to use synthetic biology R&D services to accelerate sustainable manufacturing in Japan. Stock Price, Quote, latest community messages, chart, news and other stock related information DNA Ginkgo Bioworks Holdings Inc - Ordinary Shares - Class A.
Ginkgo Ferment 2021: How to Predict a Revolution with Cathie Wood, Tom Knight, and Michael Specter
On average, Wall Street analysts predict that Ginkgo Bioworks Holdings's share price could reach $ by Jul 9, The average Ginkgo Bioworks Holdings. As of Aug the stock price of Ginkgo Bioworks is $ What is the current market cap of Ginkgo Bioworks? The current market capitalization of Ginkgo. According to Ginkgo Bioworks 's latest financial reports and stock price the company's current number of shares outstanding is 2,,, At the end of Ginkgo Bioworks is trading at as of the 29th of July , a percent up since the beginning of the trading day. The stock's open price was Ginkgo Bioworks (NYSE: DNA) reported its Q2 financial results, showing a 30% decrease in total revenue to $56 million, primarily due to the expected ramp-.